The federal contract award SPE2DB24D1205|SPE2DB25FCSSS was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $8,133.74 Firm Fixed Price contract has an ultimate completion date of December 31, 2024. This contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 4/1/25, 3:53 PM